about
[Magnetic resonance imaging and Cogan's syndrome]Validation of a portable device for mapping motor and gait disturbances in Parkinson's disease.Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation CarriersBilateral striatal lesions in childhood.Huntington's disease: confirmation of diagnosis and presymptomatic testing in Spanish families by genetic analysisClinical and imaging markers in premotor LRRK2 G2019S mutation carriers.Pelvic dyskinesia with an outstanding response to tetrabenazine.Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer's disease.Apoptosis of peripheral blood lymphocytes in Parkinson patients.Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia.Giant basilar aneurysm in the course of subacute bacterial endocarditis.Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.CSF somatostatin increase in patients with early parkinsonian syndrome.Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry.Lack of interaction of SNCA and MAPT genotypes in Parkinson's disease.Age at onset in LRRK2-associated PD is modified by SNCA variants.Further extension of the H1 haplotype associated with progressive supranuclear palsySignificant Changes in the Tau A0 and A3 Alleles in Progressive Supranuclear Palsy and Improved Genotyping by Silver DetectionFormation and growth of the cerebral convolutions. II. Cell death in the gyrus suprasylvius and adjoining sulci in the catT cell subsets in multiple sclerosis: a serial studyCerebrospinal monoamine metabolites and amino acid content in patients with parkinsonian syndrome and rats lesioned with MPP+Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion[Bilateral asymmetric degeneration of the striatum as a cause of senile hemiballism][Myastenia gravis unmasked by botulinum toxin]Electrophysiological study of ephaptic axono-axonal responses in hemifacial spasmCognitive improvement after duodenal levodopa infusion in cognitively impaired Parkinson's disease patients
P50
Q33542474-BE4804F3-FDE5-4E87-B0BA-7E04FEF56367Q35127292-7452330E-8722-4BF9-A8E0-A88D2250F52DQ35692655-9F277870-BE6E-49C5-ACD9-62990552A7F9Q36760979-348C7255-7BF0-4869-BF1B-4F26282CB08AQ36900188-1441342B-ECC2-47AA-B312-868518DF9FE4Q40608804-A0542BD6-BDFE-4B02-83B0-349F884CEF20Q46059874-4C1D843F-DDE0-4649-A348-AB5C97E2169CQ48304039-C9E3CCF8-DFE5-478A-8991-8B7DF519ECE4Q48359657-6F0060E0-5B94-4B81-A181-8BF673B99DDEQ48543932-C8F1E500-2B27-45A2-BE8A-57E1EF9F9232Q48866639-478A93D1-5019-48C2-A195-3FBC02A6BD98Q50594096-69742114-E40F-4D5F-97A4-0D1C655DFD41Q52019874-63B0ECF1-8014-461F-84D1-4F0577DD2C97Q53494922-DF49E116-F8F6-46E2-9298-0D553A3BC79BQ54403050-18113F02-7775-4F88-9600-2DBC63126C94Q54506455-20BB4D60-0BE1-4896-A942-0B86D720DD19Q57814754-74D7D9B2-B7CD-433F-98AF-E8E046DF4D4AQ57814790-30EC1677-8B58-4228-925B-A91B7C295FD8Q69598128-CB5FBD63-23F8-487E-82FE-CC8680858FC2Q71023911-516A9C90-85BD-441F-869C-E5147ECD8DB2Q72142393-ED54EA5B-BE4F-49C2-90CC-8E82B6469D8BQ72145544-ADD2D08F-9D39-4A2D-911B-2A3C181CC5B4Q73331470-60217B72-ACB9-4A58-95B0-3C680D9FBC00Q73332146-82A7E811-8633-420C-86C8-80D0F31309BDQ79291168-037E6BBA-6091-4E70-8286-BB5BD9263B82Q84840599-E4147DD2-E160-40C7-824B-F081E9412A70
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Matilde Calopa
@ast
Matilde Calopa
@en
Matilde Calopa
@es
Matilde Calopa
@nl
Matilde Calopa
@sl
type
label
Matilde Calopa
@ast
Matilde Calopa
@en
Matilde Calopa
@es
Matilde Calopa
@nl
Matilde Calopa
@sl
prefLabel
Matilde Calopa
@ast
Matilde Calopa
@en
Matilde Calopa
@es
Matilde Calopa
@nl
Matilde Calopa
@sl
P106
P31
P496
0000-0002-6943-3707